A Published and Patented Foundation

The Redox Therapeutics platform builds on peer-reviewed research in polymer nanoparticle engineering, endotoxin capture and nanoparticle-embedded filtration membranes originated at Missouri University of Science & Technology (Missouri S&T). Redox Therapeutics entered into an exclusive Licensing Agreement with Misouri S&T for the endotoxin removal technology as described in the Patent # 9,918,943.

POLYBALL™ TECHNOLOGY

Published studies have demonstrated:

100% LPS removal from endotoxin contaminated water

>99% endotoxin removal with >99% protein recovery using nanoparticle-embedded biofilters in tested recombinant protein solutions.

PATENTED PERFORMANCE

U.S. Patent 9,918,943 — Systems and Methods for Endotoxin Removal From Fluids describes polymeric nanoparticles with:

≥1 × 10⁹ EU/gEndotoxin removal capacity

≥1 × 10⁶ EU/cm²Endotoxin removal efficacy per nanoparticle surface area

KEY SCIENTIFIC FOUNDATION

Multifunctional Biofilter to Effectively Remove ToxinsACS Applied Bio Materials, 2021 ↗

PolyBall™: A New Adsorbent for the Efficient Removal of Endotoxin from BiopharmaceuticalsScientific Reports, 2019 ↗

Endotoxin hitchhiking on polymer nanoparticlesNanotechnology, 2016 ↗

Redox Therapeutics is advancing this scientific foundation from controlled protein and fluid systems toward therapeutic plasma filtration.